EXAGEN INC. Quarterly Depreciation, Depletion and Amortization in USD from Q3 2018 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Exagen Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q3 2018 to Q3 2024.
- Exagen Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $400K, a 33.3% decline year-over-year.
- Exagen Inc. Depreciation, Depletion and Amortization for the twelve months ending September 30, 2024 was $1.8M, a 21.7% decline year-over-year.
- Exagen Inc. annual Depreciation, Depletion and Amortization for 2023 was $2.2M, a 37.5% increase from 2022.
- Exagen Inc. annual Depreciation, Depletion and Amortization for 2022 was $1.6M, a 77.8% increase from 2021.
- Exagen Inc. annual Depreciation, Depletion and Amortization for 2021 was $900K, a 80% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)